Date closed: 6/17/2015

Value: C$25 million

On June 17, 2015, Tribute Pharmaceuticals Canada Inc. (Tribute) completed the acquisition of Medical Futures Inc. (MFI) in a transaction valued at C$25 million.

MFI, headquartered in Markham, Ontario, is a Canadian based specialty pharmaceutical company.

Tribute, headquartered Milton, Ontario, is a specialty pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada and the U.S. markets.

BLG represented MFI and the vendors with a team led by Graham King that included Lydia Wakulowsky and Kyle Denomme (Corporate Commercial), Natasha Miklaucic and Steve Suarez (Tax), Michael C. DeCosimo (Securities & Capital Markets), Brennan Carroll (Commercial Real Estate), Brandon Evenson (Intellectual Property), Robert Weir and James Fu (Labour & Employment), and Rick Coburn (Environmental).